Search Login Register

Fluorodeoxyglucose F18 (Fludeoxyglucose F 18) Summary

Description: The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)

Also Known As: Fludeoxyglucose F 18; 18F-FDG; Fluorine-18-fluorodeoxyglucose; Fluorodeoxyglucose F 18; 2 Fluoro 2 deoxy D glucose Show All >>

Networked: 3728 relevant articles (103 outcomes, 510 trials/studies) for this Drug

Key Diseases for which Fluorodeoxyglucose F18 is Relevant

  1. Neoplasms (Cancer) : 38 outcomes 120 studies in 852 results
  2. Neoplasm Metastasis (Metastasis) : 13 outcomes 45 studies in 383 results
  3. Breast Neoplasms (Breast Cancer) : 5 outcomes 23 studies in 182 results
  4. Glioma (Gliomas) : 5 outcomes 14 studies in 60 results
  5. Lung Neoplasms (Lung Cancer) : 4 outcomes 17 studies in 111 results
Show All >>

Drugs Related to Fluorodeoxyglucose F18

  1. Glucose (Dextrose)
  2. Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
  3. fluoromisonidazole
  4. alovudine
  5. Insulin (Novolin)
  6. Blood Glucose (Blood Sugar)
  7. Biological Markers (Surrogate Marker)
  8. Biological Tumor Markers (Tumor Markers)
  9. methionine methyl ester
  10. Ganciclovir (Cytovene)
Show All >>

Therapies Related to Fluorodeoxyglucose F18

  1. Drug Therapy (Chemotherapy)
  2. Radiotherapy
  3. Heterologous Transplantation (Xenotransplantation)
  4. Aftercare (After-Treatment)
  5. Electrodes (Electrode)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.